Thomas P. Bersot, MD, PhD

Associate Investigator

Phone: (415) 734-2027
Fax: (415) 355-0919
Fewer scientific details, please
Download a Printable PDF

Other Professional Titles

Director of the Gladstone Lipid Clinic

Clinical Professor of Medicine, University of California, San Francisco

Administrative Assistant

Sylvia Richmond
(415) 734-2062
srichmond@gladstone.ucsf.edu

More about Dr. Bersot

Dr. Bersot’s work focuses on the genetic disorders of cholesterol metabolism. At the Lipid Clinic, which began as a resource for GICD, he provides patient care and teaches healthcare providers and community members about research related to blood lipid (cholesterol) disorders and coronary heart disease prevention. Dr. Bersot also established the Gladstone Lipid Clinic Outreach Program and the Lipid Disorders Training Center. These programs also teach healthcare providers about the latest advances in heart disease prevention.

Dr. Bersot has received numerous awards and honors, including the Nutritional Lipid Association Service Award for Past Presidents, the American Heart Association Special Recognition Award for Teaching, Service, and Leadership by the Council of Arteriosclerosis, Thrombosis, and Vascular Biology, and the Clinical Mentoring Recommendation by the UCSF School of Pharmacy.

As a member of the American Heart Association, Dr. Bersot serves on the Council on Arteriosclerosis, Thrombosis, and Vascular Biology and on the Clinical Affairs Committee.  He also serves as chairperson of one of four ethics panels that review all clinical research protocols at UCSF.  

Prior to joining Gladstone at its inception in 1979, Dr. Bersot served as Chief Resident of the National Heart, Lung, and Blood Institute at the National Institutes of Health.

Dr. Bersot earned a bachelor degree from the University of Kentucky and an MD and PhD from Vanderbilt University. He completed his medical residency at UCSF.

More scientific details, please

Other Professional Titles

Director of the Gladstone Lipid Clinic

Clinical Professor of Medicine, University of California, San Francisco

Administrative Assistant

Sylvia Richmond
(415) 734-2062
srichmond@gladstone.ucsf.edu

Areas of Investigation

My work focuses on the management of and teaching about heart disease and stroke prevention. Studies of lipid metabolism here at Gladstone and elsewhere have provided insights that are applied to care of patients with difficult to manage plasma cholesterol problems. This expertise is communicated to healthcare providers and the community through the Gladstone Outreach Program. My experience in clinical research led to an interest in the ethical conduct and treatment of patients participating in clinical research. Currently, I am the chairperson of one of four ethics panels that review all of the clinical research protocols at the University of California, San Francisco (UCSF), including the studies conducted by investigators at the Gladstone Institutes.

The activities of the Outreach Program include patient care, teaching and research related to blood lipid (cholesterol) disorders and coronary heart disease (CHD) prevention. Patient care is delivered through the Gladstone Lipid Clinic, which also serves as a demonstration clinic for teaching students, residents and fellows of the UCSF Schools of Medicine and Pharmacy. The Gladstone Lipid Disorders Training Center is an educational program for postgraduate healthcare professionals.

In addition to the instruction of students and physicians in the Gladstone Lipid Clinic, we offer courses for postgraduate physicians in the Lipid Disorders Training Center. A 2 1/2 day mini-fellowship is offered for those seeking comprehensive knowledge about the management of cardiovascular risk factors. A highlight of the mini-fellowships is a one-day demonstration clinic during which course participants see 8–10 patients in the Gladstone Lipid Clinic. One-day Update courses offer guidance about patient management based on the results of recent advances in basic and clinical science.

Current Focus

  • Managing the treatment of patients with difficult problems in lipid metabolism.
  • Training healthcare providers in the best ways to manage lipid metabolism.

Joined Gladstone

1979. I was one of the original scientists of the Gladstone Institute of Cardiovascular Disease.

Why Gladstone?

I became interested in the biology of plasma lipid metabolism and atherosclerosis when I began my career in research and medicine as a medical student. It was then that I met and began to work with Gladstone Founding President Robert W. Mahley, MD, PhD. We have worked together since then, including the pivotal start of the first Gladstone Institute, the Gladstone Institute for Cardiovascular Disease. I have stayed because of the research and teaching opportunities, which are simply outstanding. It is truly an exciting and rewarding place to work.

Key Achievements

  • Delineated of the liver’s role in the formation of lipoproteins prior to their secretion into the blood.
  • Identified apoE as a ligand of the low-density lipoprotein receptor.
  • Initialized the lipid clinic program at the San Francisco General Hospital.

Education

University of Kentucky (BA)
Vanderbilt University (MD, PhD)
University of California, San Francisco (residency in medicine)
National Institutes of Health (chief resident)

Affiliations

American Heart Association
National Lipid Association
US Food and Drug Administration Endocrine and Metabolic Drug Advisory Committee

Awards

  • Best Doctors in America (2001)
  • Clinical Mentoring Commendation, UCSF School of Pharmacy (2004)
  • American Heart Association Special Recognition Award for Teaching, Service, and Leadership by the Council of Arteriosclerosis, Thrombosis, and Vascular Biology (2006)
  • Nutritional Lipid Association Service Award for Past Presidents (2009)
Syndicate publications

Featured Publications

Tom Bersot, MD, PhDCan AS, Yildiz EA, Samur G, Rakicioglu N, Pekcan G, Ozbayrakçi S, Palaoglu KE, Gönen M, Bersot TP. Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults. Public Health Nutr. 2010 Apr; 13(4):488-95. View in: PubMed